Your browser doesn't support javascript.
loading
The need for affordable, pragmatic, investigator-led clinical trials of treatment strategies in inflammatory bowel disease.
Noor, Nurulamin M; Sebastian, Shaji; Parkes, Miles; Raine, Tim.
Affiliation
  • Noor NM; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK. Electronic address: nn281@cam.ac.uk.
  • Sebastian S; Gastroenterology and Hepatology, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK; Hull York Medical School, University of Hull, Hull, UK.
  • Parkes M; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Raine T; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Lancet Gastroenterol Hepatol ; 9(10): 900-903, 2024 Oct.
Article in En | MEDLINE | ID: mdl-39094586

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases Limits: Humans Language: En Journal: Lancet Gastroenterol Hepatol Year: 2024 Document type: Article Country of publication: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases Limits: Humans Language: En Journal: Lancet Gastroenterol Hepatol Year: 2024 Document type: Article Country of publication: Países Bajos